Boston Scientific Scimed, Inc.

Boston Scientific Corporation

Hamid Davoudi

Jianmin Li

Jozef Slanda

Michael S H Chu

Isaac Ostrovsky

Robert T Miragliuolo

Raymond Lareau

Alfred P Intoccia, Jr

Michael Madden

Alfred Intoccia

Kathleen M Miller

Cang D Dao

Danielle Conley

Michael F Weiser

James M Goddard

Ty Fairneny

Weenna Bucay-Couto

Roger P Goldberg

Steven A Olivieri

John Petricca

Weenna Bucay Couto

Ken Toso

Isacc Ostrovsky

Jianmin (Jamie) Li

Cang Duy Dao

In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.

Porous ureteral stent

In some embodiments, a ureteral stent includes an elongate member having a first portion and a second portion, which is coupled to the first portion. The first portion of the elongate member is configured to be disposed within a kidney of a patient. The second portion of the elongate member, which has a sidewall that defines a lumen, is configured to deliver fluid from a first location of the sidewall of the second portion to a second location of the sidewall of the second portion via capillary action. The second portion of the elongate member is configured to be disposed within at least one of a bladder and a ureter of the patient.

Ureteral stent

In one embodiment, a method includes securing an implant that includes a pre-formed loop to a vaginal apex. An end of the suture is inserted through a selected portion of a pelvic tissue to dispose at least a portion of the implant within a pelvic region of the patient. The end of the suture is drawn through the loop while simultaneously advancing a uterus to approximate the vaginal apex to the selected portion of pelvic tissue. An apparatus includes an implant and a suture coupled to the implant having a pre-formed loop. configured to receive a portion of a delivery device therethrough. A trocar is coupled to an end of the suture that can be releasably coupled to an end of the delivery device. The trocar can be inserted through a pelvic tissue and drawn through the loop forming a knot to secure the implant to the pelvic tissue.

Devices and method for treating pelvic dysfunctions

In one embodiment, a medical device includes an elongate member configured to be inserted into a body. The elongate member has a first end portion and a second end portion opposite the first end portion. The elongate member includes a retaining member extending from the elongate member. The retaining member is configured to anchor the elongate member with respect to bodily tissue. The first end portion of the elongate member includes a coupling portion configured to be coupled to a filament. The second end portion of the elongate member includes a coupling portion configured to be coupled to the filament.

Surgical composite barbed suture

According to one claim of the invention, a method for occluding a fallopian tube in a vertebrate subject is described, which comprises comprising transcervically delivering a solid blocking material into the fallopian tube. In various embodiments, a fluid sealing material is delivered along with the solid blocking material. Other claims of the invention pertain to articles of manufacture, delivery devices and kits for use in occluding the fallopian tubes of a vertebrate subject.

Occlusion of fallopian tubes in a vertebrate subject

The invention relates generally to surgical implants, and in various embodiments to surgical implants configured for promoting growth of collagenous tissue at an anatomical site.

Surgical slings

Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.

Implantable or insertable medical devices for controlled drug delivery

Growing community of inventors

Westwood, MA, United States of America

Hamid Davoudi